(Q53755018)

19 May 2018

title

Effects of alosetron on gastrointestinal transit time and rectal sensation in patients with irritable bowel syndrome. (English)

1 reference

19 May 2018

1 reference

Thumshirn M

1

1 reference

19 May 2018

Coulie B

2

1 reference

19 May 2018

Camilleri M

3

1 reference

19 May 2018

Zinsmeister AR

4

1 reference

19 May 2018

Burton DD

5

1 reference

19 May 2018

Van Dyke C

6

1 reference

19 May 2018

language of work or name

English

0 references

publication date

1 July 2000

1 reference

19 May 2018

Alimentary Pharmacology & Therapeutics

published in

1 reference

19 May 2018

volume

14

1 reference

19 May 2018

issue

7

1 reference

19 May 2018

page(s)

869-878

1 reference

19 May 2018

Irritable bowel syndrome: a technical review for practice guideline development

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00786.X

Review article: irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00786.X

Irritable bowel syndrome in office-based practice in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00786.X

Jejunal sensorimotor dysfunction in irritable bowel syndrome: clinical and psychosocial features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00786.X

Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00786.X

Altered rectal perception is a biological marker of patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00786.X

Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00786.X

The effects of granisetron, ICS 205-930 and ondansetron on the visceral pain reflex induced by duodenal distension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00786.X

Selective 5-hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00786.X

Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00786.X

GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00786.X

Serotonergic mediation of postprandial colonic tonic and phasic responses in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00786.X

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00786.X

Towards positive diagnosis of the irritable bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00786.X

Psychosensory modulation of colonic sensation in the human transverse and sigmoid colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00786.X

Autonomic control of colonic tone and the cold pressore test

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00786.X

Manovolumetry: a new method for investigation of anorectal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00786.X

Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00786.X

The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00786.X

Central modulation of rectal distension-induced blood pressure changes by alosetron, a 5-HT3 receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00786.X

Differences between males and females in rates of serotonin synthesis in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00786.X

10.1046/J.1365-2036.2000.00786.X

21 January 2018

Identifiers

DOI

1 reference

19 May 2018

1 reference

19 May 2018